Tower Capital, Temasek Joins $196M Take-Private Bid For Eu Yan Sang

Login to View

Tower Capital and Temasek Holdings have joined company founders to submit a bid to take Singapore-listed traditional Chinese medicine firm Eu Yan Sang International private in a deal that values the company at S$269 million (US$196 million).

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

China Money Network Subscription